1. Stocks
  2. Fulcrum Therapeutics Inc
  3. Swot
swot-logo

Fulcrum Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Fulcrum Therapeutics Inc has 18 Strengths, 8 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout Third Resistance ( LTP > R3)

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Positive Breakout (LTP > R2)

Positive breakout third resistance ( LTP > R3)

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Low DVM Stocks - Stocks to Exercise Caution On

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Highest fall from 52 Week High

Low Piotroski Score : Companies with weak financials

Stocks Underperforming their Industry Price Change in the Quarter

Institutions increasing their shareholding

Mutual Funds Decreased Shareholding in Past Month

MFs decreased their shareholding last quarter